← Leaderboards
Paulo R. Shiroma
Minneapolis Va Medical Center
$0
Attributed
$0
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2015–25$1$1$1$0$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 2
By mechanism
I01$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Secondary Outcome”
- David M Nathan · Massachusetts Institute Of Technology$141,712,864
- Randall J Bateman · Washington University$132,029,306
- John M Lachin · George Washington University$118,921,924
- Eric Martin McDade · Washington University$96,219,353
- Reisa A. Sperling · Banner Health$94,788,191
- Paul S. Aisen · Cognition Therapeutics, Inc.$92,171,509
Research focus
Secondary OutcomeResponseFollow-UpMental DepressionPost-Traumatic Stress DisordersRelapseDepressive SymptomsFemaleKetamineInterviewN-MethylaspartateMilitary PersonnelPharmaceutical PreparationsPlacebosAcuteAnestheticsDisease RemissionDoseAnxietyClinical TrialsHourInfusion ProceduresMidazolamSeverities
Grant awards (9)
Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD$0
I01 · FY2025 · VA · contact PI
Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD$0
I01 · FY2024 · VA · contact PI
Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD$0
I01 · FY2023 · VA · contact PI
Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD$0
I01 · FY2022 · VA · contact PI
Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD$0
I01 · FY2021 · VA · contact PI
Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant Depression$0
I01 · FY2018 · VA · contact PI
Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant Depression$0
I01 · FY2017 · VA · contact PI
Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant Depression$0
I01 · FY2016 · VA · contact PI
Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant Depression$0
I01 · FY2015 · VA · contact PI